Evidence map›Paper›PMID 34937389›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2022

Atomic Level Dissection of the Platelet Endothelial Cell Adhesion Molecule 1 (PECAM-1) Homophilic Binding Interface: Implications for Endothelial Cell Barrier Function.

Danying Liao, Jesse Sundlov, Jieqing Zhu, Heng Mei, Yu Hu, Debra K Newman, Peter J Newman

Open access · bronzeAbstract read
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Interferon-mediated regulation of the neurovascular unit in diabetic retinopathy.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Danying Liao *Blood Research Institute, Versiti Blood Center of Wisconsin, Milwaukee (D.L., J.S., J.Z., D.K.N., P.J.N.).
Jesse Sundlov *Blood Research Institute, Versiti Blood Center of Wisconsin, Milwaukee (D.L., J.S., J.Z., D.K.N., P.J.N.).
Jieqing ZhuBlood Research Institute, Versiti Blood Center of Wisconsin, Milwaukee (D.L., J.S., J.Z., D.K.N., P.J.N.).
Heng MeiInstitute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, China (D.L., H.M., Y.H., P.J.N.).
Yu HuInstitute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, China (D.L., H.M., Y.H., P.J.N.).ORCID 0000-0002-2815-4568
Debra K NewmanBlood Research Institute, Versiti Blood Center of Wisconsin, Milwaukee (D.L., J.S., J.Z., D.K.N., P.J.N.).ORCID 0000-0001-9674-0801
Peter J NewmanBlood Research Institute, Versiti Blood Center of Wisconsin, Milwaukee (D.L., J.S., J.Z., D.K.N., P.J.N.).ORCID 0000-0001-8853-7707
Medical College of Wisconsin · USUnion Hospital · CNVersiti Blood Center of Wisconsin · US

Funding

MOLECULAR BIOLOGY &FUNCTION OF PLATELET MEMBRANE GP130R01HL040926 · NHLBI · VERSITI WISCONSIN, INC. · PI NEWMAN, PETER J · 1988 to 2017
$7.4M
Basic Investigation and Translational Applications Concerning the Cell and Molecular Biology of Blood and Vascular CellsR35HL139937 · NHLBI · VERSITI WISCONSIN, INC. · PI NEWMAN, PETER J · 2018 to 2024
$6.9M
Structural Transition of Cellular Integrins and Applications ThereofR01HL131836 · NHLBI · VERSITI WISCONSIN, INC. · PI Jieqing Zhu · 2016 to 2026
$5.5M
Structural Mechanisms Underlying the Activity Regulation of the Receptor-like Protein Tyrosine Phosphatase, CD148/PTPRJR01GM137143 · NIGMS · VERSITI WISCONSIN, INC. · PI ZHU, JIEQING · 2020 to 2023
$1.4M
NHLBI NIH HHS R01 HL040926NHLBI NIH HHS R01 HL131836NHLBI NIH HHS R35 HL139937NIGMS NIH HHS R01 GM137143
6 · The paper itself

Abstract

objectivePECAM-1 (platelet endothelial cell adhesion molecule 1) is a 130 kDa member of the immunoglobulin (Ig) gene superfamily that is expressed on the surfaces of platelets and leukocytes and concentrated at the intercellular junctions of confluent endothelial cell monolayers. PECAM-1 Ig domains 1 and 2 (IgD1 and IgD2) engage in homophilic interactions that support a host of vascular functions, including support of leukocyte transendothelial migration and the maintenance of endothelial junctional integrity. The recently solved crystal structure of PECAM-1 IgD1 and IgD2 revealed a number of intermolecular interfaces predicted to play important roles in stabilizing PECAM-1/PECAM-1 homophilic interactions and in formation and maintenance of endothelial cell-cell contacts. We sought to determine whether the protein interfaces implicated in the crystal structure reflect physiologically important interactions. Approach and Results: We assessed the impact of single amino acid substitutions at the interfaces between opposing PECAM-1 molecules on homophilic binding and endothelial cell function. Substitution of key residues within the IgD1-IgD1 and IgD1-IgD2 interfaces but not those within the smaller IgD2-IgD2 interface, markedly disrupted PECAM-1 homophilic binding and its downstream effector functions, including the ability of PECAM-1 to localize at endothelial cell-cell borders, mediate the formation of endothelial tubes, and restore endothelial barrier integrity.

conclusionsTaken together, these results validate the recently described PECAM-1 IgD1/IgD2 crystal structure by demonstrating that specific residues visualized within the IgD1-IgD1 and IgD1-IgD2 interfaces of opposing molecules in the crystal are required for functionally important homophilic interactions. This information can now be exploited to modulate functions of PECAM-1 in vivo.

Indexed as

Cell AdhesionCell CommunicationEndothelial CellsHumansHuman Umbilical Vein Endothelial CellsModels, MolecularPlatelet Endothelial Cell Adhesion Molecule-1Protein BindingPECAM1 protein, humanPlatelet Endothelial Cell Adhesion Molecule-1lymphocytesmonocytesneutrophilsPECAM-1platelet

Identifiers

PMID34937389
PMCPMC8942131
OpenAlexW4200295300

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.